At The Cutting Edge of Science

Biogelx is a biomaterials company which designs and supplies peptide hydrogels for cell culture, precisely tuned to the requirements of the cell. These products have applications in fundamental cell research, toxicology/drug development and may ultimately be translated to cell therapy/regenerative medicine. The chemical and physical properties of the hydrogels match the characteristics experienced by cells within tissues, thus enabling the study and manipulation of cells in a realistic 3D environment which is simple, fully defined and tuneable.

The Company's patented hydrogel products are currently selling in the US, Europe and Asia.

The product's unique cell-matching capabilities clearly provide academic users, medical researchers and pharmaceutical companies with a serious alternative to competing 3D cell culture products.

Management Team

Douglas Hutchison Chairman Douglas is an inspiring and visionary leader with significant commercial acumen and proven ability to contribute at the highest level. He has a track record of leading start-ups to successful exit. Linked In
David Lightbody CEO David Lightbody has over twenty years senior experience building innovative technology businesses both in Europe and the United States, where he was based for over ten years (Chicago and Washington DC). David holds a PhD in Chemistry and MBA from the University of Strathclyde. Linked In
Professor Rein Ulijn CSO Rein is the founding director of the ASRC’s Nanoscience Initiative at CUNY and is also the Einstein Professor of Chemistry at Hunter College. He is a pioneer in an area of nanoscience that focuses on creating materials and systems that are inspired by biology but are much simpler in their design. Linked In
Eleanore Irvine Business Development Manager Eleanore is responsible for managing new business activities and existing customer relations at Biogelx. Eleanore is a PhD chemist and a Saltire Fellow from Babson College. Linked In
Mhairi Harper Product Development Manager Mhairi directs the development of Biogelx product range through in-house activities and the management of a network of collaborative relationships with academic and industrial cell biology partners. Mhairi completed her PhD at the University of Strathclyde, specialising in nanochemistry. Linked In

Excellence Recognised

Pitch at the PalaceFinalists 2016
ENGAGE, INVEST, EXPLOITPitch of the Day Winners 2014.

Distribution Partners

North America Advanced BioMatrix
North America Cedarlane
South Korea CEFO
Israel Doron Scientific
Japan Cosmo Bio
CLICK HERE TO Chemistry World Covers BioGelX